# Syrhatech completes CHF 4.5 million financing round

Syrhatech, a CDMO specializing in injectable medical devices based on hyaluronic acid, has closed an investment of CHF 4.5 million from strategic investors. The funds will be used to strengthen its R&D team in Geneva and deploy new production capacity at its plant in Chambéry, France.

- Type: Investment
- Announced: 2025-04-01
- Where: Chambéry, France, France
- Value: $5.00M (4.50M CHF)
- Status: announced
- Products: injectable medical devices based on hyaluronic acid
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Syrhatech](https://endata.com/companies/84346.md)

## Sources

- [syrhatech.com](https://www.syrhatech.com/resources/syrhatech-completes-a-financinground-of-chf-4-5-million/), 2025-04-24: "This investment will enable Syrhatech to strengthen its R&D team at its site in Geneva, Switzerland, and to deploy a new production capacity at its plant in Chambéry, France."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.